Table 3.
Parameter (Mean ± SD) | All patients (n = 172) | Without comorbidities (n = 87) | With comorbidities (n = 85) | ||||||
---|---|---|---|---|---|---|---|---|---|
SVI | NSVI | P= | SVI | NSVI | P= | SVI | NSVI | P= | |
(n = 84) | (n = 88) | (n = 34) | (n = 53) | (n = 50) | (n = 35) | ||||
Accident-blood sample interval (hours) | 44.4 ± 76 | 49.2 ± 92 | 0.731 | 57.0 ± 100 | 39.1 ± 55 | 0.363 | 33.1 ± 42 | 64.8 ± 131 | 0.171 |
Hemoglobin (g/dL) | 15.0 ± 1.8 | 15.3 ± 1.2 | 0.177 | 15.1 ± 1.8 | 15.3 ± 1.3 | 0.408 | 14.9 ± 1.8 | 15.2 ± 0.9 | 0.309 |
Hematocrit (%) | 45.0 ± 5.0 | 45.9 ± 3.4 | 0.136 | 45.1 ± 4.4 | 46.2 ± 3.8 | 0.243 | 44.9 ± 5.5 | 45.6 ± 2.8 | 0.485 |
Leucocytes (K/uL) | 11.7 ± 4.0 | 9.4 ± 3.0 | <0.001 | 11.5 ± 3.6 | 9.3 ± 2.7 | 0.001 | 11.9 ± 4.2 | 9.6 ± 3.3 | 0.002 |
Neutrophils (K/uL) | 9.2 ± 4.1 | 6.7 ± 3.0 | <0.001 | 9.2 ± 3.9 | 6.7 ± 2.9 | 0.002 | 9.2 ± 4.3 | 6.6 ± 3.1 | 0.001 |
Lymphocytes (K/uL) | 1.7 ± 0.9 | 2.1 ± 0.9 | 0.014 | 1.5 ± 0.5 | 1.9 ± 0.8 | 0.006 | 1.8 ± 1.0 | 2.3 ± 0.9 | 0.011 |
Platelets (K/uL) | 249.0 ± 96 | 244.7 ± 54 | 0.709 | 249.7 ± 61 | 241.4 ± 48 | 0.495 | 249 ± 115 | 249.8 ± 62 | 0.954 |
NLR | 7.4 ± 6.6 | 4.0 ± 3.2 | <0.001 | 7.7 ± 6.6 | 4.4 ± 3.5 | 0.001 | 7.2 ± 6.7 | 3.5 ± 2.6 | <0.001 |
PLR | 167.2 ± 92 | 139.0 ± 64 | 0.021 | 189 ± 100 | 146.0 ± 63 | 0.018 | 152.7 ± 85 | 128.5 ± 65 | 0.160 |
MXD | 0.8 ± 0.4 | 0.8 ± 0.3 | 0.304 | 0.7 ± 0.3 | 0.7 ± 0.3 | 0.830 | 0.9 ± 0.4 | 0.8 ± 0.4 | 0.508 |
Glucose (mg/dL) | 124.8 ± 50 | 106.5 ± 35 | <0.001 | 115.1 ± 36 | 99.0 ± 15 | 0.070 | 130.2 ± 56 | 117.4 ± 51 | 0.019 |
SVI, Severe visual impairment; NSVI, Non-SVI; OGI, Open globe injury; SD, Standard deviation; NLR, Neutrophil-to-lymphocyte ratio; PLR, Platelet-to-lymphocyte ratio.
Bold means p < 0.05.